IVIG treatments for Bell's palsy
US11083789B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Oct 8, 2020 |
| Grant date | Aug 10, 2021 |
| Priority date | — |
| Expiry date | Oct 8, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides, among other aspects, methods and compositions for treating Bell's Palsy disease in a subject in need thereof, the method comprising: administering a therapeutically effective amount of a composition comprising human intravenous immunoglobulin (IVIG) to a subject. The present invention also provides, methods and composition for treating Bell's Palsy disease in a subject in need thereof, the method comprising: administering a therapeutically effective amount of a composition comprising human IVIG and a steroid. In certain aspects of the present invention the steroid is a cortical steroid, including Prednison.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.